Cost effective analysis: Decision analysis & pneumatic retinopexy versus scleral buckling surgery

Evidence-Based Eye Care

Volumn 2, Issue 4, 2001, Pages 243-249

  Sharma, Sanjay ^a   Robbins, Ron ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CATARACT; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; MALE; MEDICAL DECISION MAKING; MONTE CARLO METHOD; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RATING SCALE; RETINA DETACHMENT; RETINOPEXY; SCLERA BUCKLING PROCEDURE; SENSITIVITY ANALYSIS; UTILIZATION REVIEW;

EID: 0041632160     PISSN: 15258599     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132578-200110000-00028     Document Type: Article

References (26)

1. Branch Retinal Vein Occlusion Study Group. Argon laser for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98:271-282.
2. Weinstein MC, Stasson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296:716-721.
3. Gold ME, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
4. Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities and quality of life. Curr Opin Ophthalmol 1999; 10:221-228.
5. Angell M. Patients' preferences in randomized clinical trials. N Engl J Med 1984; 310:1385-1387.
6. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330: 1895-1896.
7. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994; 112:630-638.
8. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992; 30:473-483.
9. Redelmeier DA, Detsky AS. A clinician's guide to utility measurement. In: Bergus GR, Cantor SB, eds, Primary Care Clinics in Office Practice. Philadelphia: WB Saunders, 1995:271-280.
10. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decision Making 1993; 13:322-338.
11. Damodaran A. Corporate Finance: Theory and Practice. New York: John Wiley & Sons, 1997:37-65.
12. Brown GC, Brown MM, Sharma S, Tasman W, Brown H. Cost-effectiveness of treatment for threshold retinopathy of prematurity. Pediatrics 1999;104:e47.
13. Laupacis A. Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization. Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146:473-481.
14. Benson WE, Chan P, Sharma S, et al. Current popularity of pneumatic retinopexy. Retina 1999; 19:238-241.
15. Tornambe PE, Hilton GF. Pneumatic retinopexy: a multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmology 1989; 96:772-784.
16. Tornambe PE, Hilton GF, Brinton DA, et al. Pneumatic retinopexy: a two-year follow-up study of the multicenter clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmology 1991; 98:1115-1123.
17. Kiberd BA, Larson T. Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis. Transplantation 2000; 70:1121-1127.
18. Sharma S, Brown GC, Brown MM, et al. Converting visual acuities to utilities. Can J Ophthalmol 2000; 35:267-272.
19. Brown MM, Brown GC, Sharma S, et al. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999; 110: 221-226.
20. Brown GC, Brown MM, Sharma S. Utility values and age related macular degeneration. Arch Ophthalmol 2000; 118:47-51.
21. Brown MM, Brown GC, Sharma S, et al. Utility values and diabetic retinopathy. Am J Ophthalmol 1999; 128:324-330.
22. Data 3.5 Healthcare User's Manual. Treeage Software, Inc. Williamstown, MA, 1999.
23. Rosner B. Fundamentals of Biostatistics, 4th edition. Toronto: Duxbury Press, 1995.
24. Sharma S, Brown GC, Brown MM, et al. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology (in press).
25. Sharma S, Hollands H, Brown GC, et al. Cost-effectiveness of early vitrectomy in the treatment of bilateral severe vitreous hemorrhage in diabetic retinopathy. Curr Opin Ophthalmol (in press).
26. Sharma S, Brown GC, Brown MM, et al. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol. 2000;11:175-179.